ES2071710T3 - Proceso para preparar los derivados peptidos y sus sales con acidos o bases farmaceuticamente aceptables. - Google Patents

Proceso para preparar los derivados peptidos y sus sales con acidos o bases farmaceuticamente aceptables.

Info

Publication number
ES2071710T3
ES2071710T3 ES90114307T ES90114307T ES2071710T3 ES 2071710 T3 ES2071710 T3 ES 2071710T3 ES 90114307 T ES90114307 T ES 90114307T ES 90114307 T ES90114307 T ES 90114307T ES 2071710 T3 ES2071710 T3 ES 2071710T3
Authority
ES
Spain
Prior art keywords
alkyl
bases
salts
pharmaceutically acceptable
acceptable acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90114307T
Other languages
English (en)
Inventor
Tiberio Bruzzese
Massimo Signorini
Alberto Carlo Fanciano
Roberta Termini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prodotti Antibiotici SpA
Original Assignee
Prodotti Antibiotici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prodotti Antibiotici SpA filed Critical Prodotti Antibiotici SpA
Application granted granted Critical
Publication of ES2071710T3 publication Critical patent/ES2071710T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

DERIVADOS DE PEPTIDA Y SUS SALES CON ACIDOS O BASES ACEPTABLES FARMACEUTICAMENTE, QUE TIENEN LA FORMULA GENERAL (I), EN DONDE R= -H, C1-C3 ALQUILO, C1-C3 ACILO, ALCOXICARBONILO CON ALQUILO C1-C4; R1 = -H, ALQUILO C1-C3; R2 = -H, -OH, -OR2, EN DONDE R''2 = ALQUILO C1-C3, ACILO C1-C3, BENCILO; R3 = -H, -CH3; N = 1,2 R4 = -H, -COOH, -CONH2, -COOR''4, EN DONDE R''4 = ALQUILO C1-C3, BENCILO; R5 = -H, 4-OH, 3,4-OH, -OR''5 EN DONDE R''5 = ALQUILO C1-C3, ACILO C1-C3, BENCILO; R6 = -OH, -NH2, -OR''6 EN DONDE R''6 = ALQUILO C1-C3, BENCILO; TERMINADO CON PROPIEDADES FARMACOLOGICAS DE INMUNO MODULACION, ANALGESICAS Y ANTIVIRICAS. TAMBIEN LAS FORMAS FARMACOLOGICAS QUE LO CONTIENEN COMO INGREDIENTE ACTIVO.
ES90114307T 1989-08-28 1990-07-26 Proceso para preparar los derivados peptidos y sus sales con acidos o bases farmaceuticamente aceptables. Expired - Lifetime ES2071710T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8921567A IT1231342B (it) 1989-08-28 1989-08-28 Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
ES2071710T3 true ES2071710T3 (es) 1995-07-01

Family

ID=11183718

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90114307T Expired - Lifetime ES2071710T3 (es) 1989-08-28 1990-07-26 Proceso para preparar los derivados peptidos y sus sales con acidos o bases farmaceuticamente aceptables.

Country Status (8)

Country Link
US (1) US5182265A (es)
EP (1) EP0421074B1 (es)
JP (1) JPH0390098A (es)
KR (1) KR910004659A (es)
DE (1) DE69018914T2 (es)
ES (1) ES2071710T3 (es)
IT (1) IT1231342B (es)
PT (1) PT95112B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL147970A0 (en) * 1999-08-09 2002-09-12 Tripep Ab Pharmaceutical compositions containing tripeptides
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
JP4896333B2 (ja) 2000-02-07 2012-03-14 ウイスコンシン アラムニ リサーチ ファンデーション 薬理活性抗ウイルスペプチドおよびそれらの使用法
US6593455B2 (en) 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US6455670B1 (en) 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
WO2003024995A1 (en) 2001-09-19 2003-03-27 Tripep Ab Molecules that block viral infectivity and methods of use thereof
WO2005060541A2 (en) * 2003-12-01 2005-07-07 Wisconsin Alumni Research Foundation Peptides and methods for inducing cellular resistance to infection
KR200447742Y1 (ko) * 2009-07-10 2010-02-12 조용진 법단

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1063727A (en) * 1965-04-12 1967-03-30 Ici Ltd Amide derivatives
GB1465235A (en) * 1975-04-29 1977-02-23 Sagami Chem Res Process for preparing peptides
GB8322414D0 (en) * 1983-08-19 1983-09-21 Szelke M Renin inhibitors
JPS61148198A (ja) * 1984-12-22 1986-07-05 Ajinomoto Co Inc 新規トリペプチド化合物および甘味剤
IT1190433B (it) * 1985-12-11 1988-02-16 Prodotti Antibiotici Spa Peptidi correlati al lisozima

Also Published As

Publication number Publication date
US5182265A (en) 1993-01-26
PT95112A (pt) 1991-04-18
IT1231342B (it) 1991-11-28
DE69018914D1 (de) 1995-06-01
PT95112B (pt) 1997-04-30
KR910004659A (ko) 1991-03-29
JPH0390098A (ja) 1991-04-16
DE69018914T2 (de) 1995-11-16
EP0421074A1 (en) 1991-04-10
EP0421074B1 (en) 1995-04-26
IT8921567A0 (it) 1989-08-28

Similar Documents

Publication Publication Date Title
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
MX9306986A (es) Composiciones farmaceuticas a base de taxoides.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
ES2113881T3 (es) Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales.
ES2063013T3 (es) Procedimiento para eliminar pirogenos.
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ATE51522T1 (de) Formulierung nicht irritierender ophthalmischer waesseriger zusammensetzungen fuer okulartherapeutische mittel.
ES2110761T3 (es) Pirrolidin-3-il-alquil-piperidinas sustituidas utiles como antagonistas de la taquiquinina.
ES2053451T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
MX9300014A (es) Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion.
UY25242A1 (es) Inhibidores de benzotiazol de la proteína tirosina cinasa
ES2084073T3 (es) Aclarados finales libres de cromo para metal fosfatado.
AR219543A1 (es) Procedimiento para la preparacion de un nuevo derivado aminico de di-o-(1-alquilo o alquenilo c12-c20)glicerol y sus sales de adicion de acido farmaceuticamente aceptables,utiles para combatir las infecciones viricas en los mamiferos
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2051678T1 (es) Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos.
ES2061546T3 (es) Compuestos quelantes de piridoxamina, quelatos de manganeso (ii) y su uso como agentes de contraste de nmri.
MX9400037A (es) Composicion oftalmica para el tratamiento de glaucoma e hipertension ocular.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2071710T3 (es) Proceso para preparar los derivados peptidos y sus sales con acidos o bases farmaceuticamente aceptables.
MX9300399A (es) Derivados heterotriciclicos.
ES2093782T3 (es) Piridazindionas y su uso en el tratamiento de trastornos neurologicos.
MX9205123A (es) Derivados de 5-hidroxi-2-pirimidinilmetileno utiles como agentes anti-inflamatorios.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 421074

Country of ref document: ES